-
Something wrong with this record ?
New approach of validation using internal normalization technique for quantification of related substances in raw material, intermediates and pharmaceutical substances by HPLC
M. Douša, P. Gibala, T. Pekárek,
Language English Country England, Great Britain
Document type Journal Article, Validation Study
- MeSH
- Chemistry, Pharmaceutical standards MeSH
- Calibration MeSH
- Hydrogen-Ion Concentration MeSH
- Pharmaceutical Preparations chemistry MeSH
- Limit of Detection MeSH
- Prasugrel Hydrochloride analysis MeSH
- Reproducibility of Results MeSH
- Chromatography, High Pressure Liquid methods standards MeSH
- Publication type
- Journal Article MeSH
- Validation Study MeSH
Internal normalization (IN) serves as a quantitative tool in gas chromatography. Nevertheless, its utilization in liquid chromatography is not widely employed, as several requirements need to be taken into account. However, IN can be used in case of relative amounts estimation when the absolute concentration is not the crucial factor. This suits very well in pharmaceutical analysis when the relative amount of active pharmaceutical ingredient (API) impurities is to be estimated with a limited knowledge of statistics, such as t-test and linear regression. The determination of three prasugrel impurities in the real sample by means of IN and the comparison of these results with external standard calibration was presented. The IN method was validated by test of population means and variances agreement and the agreement of external calibration and IN was performed by Student t-test. The influence of impurities concentration above and below is also discussed as well as the validation parameters, LOD and LOQ. It was found that the results achieved by external calibration and IN are statistically the same and, therefore, IN is a proper method for relative amount estimation of API impurities.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020716
- 003
- CZ-PrNML
- 005
- 20160729105209.0
- 007
- ta
- 008
- 160722s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jpba.2015.05.015 $2 doi
- 024 7_
- $a 10.1016/j.jpba.2015.05.015 $2 doi
- 035 __
- $a (PubMed)26037162
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Douša, Michal $u Zentiva, k.s. Praha, a Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic. Electronic address: michal.dousa@seznam.cz.
- 245 10
- $a New approach of validation using internal normalization technique for quantification of related substances in raw material, intermediates and pharmaceutical substances by HPLC / $c M. Douša, P. Gibala, T. Pekárek,
- 520 9_
- $a Internal normalization (IN) serves as a quantitative tool in gas chromatography. Nevertheless, its utilization in liquid chromatography is not widely employed, as several requirements need to be taken into account. However, IN can be used in case of relative amounts estimation when the absolute concentration is not the crucial factor. This suits very well in pharmaceutical analysis when the relative amount of active pharmaceutical ingredient (API) impurities is to be estimated with a limited knowledge of statistics, such as t-test and linear regression. The determination of three prasugrel impurities in the real sample by means of IN and the comparison of these results with external standard calibration was presented. The IN method was validated by test of population means and variances agreement and the agreement of external calibration and IN was performed by Student t-test. The influence of impurities concentration above and below is also discussed as well as the validation parameters, LOD and LOQ. It was found that the results achieved by external calibration and IN are statistically the same and, therefore, IN is a proper method for relative amount estimation of API impurities.
- 650 _2
- $a kalibrace $7 D002138
- 650 _2
- $a farmaceutická chemie $x normy $7 D002626
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $x normy $7 D002851
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a limita detekce $7 D057230
- 650 _2
- $a léčivé přípravky $x chemie $7 D004364
- 650 _2
- $a prasugrel hydrochlorid $x analýza $7 D000068799
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a validační studie $7 D023361
- 700 1_
- $a Gibala, Petr $u Zentiva, k.s. Praha, a Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Pekárek, Tomáš $u Zentiva, k.s. Praha, a Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 773 0_
- $w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 114, č. - (2015), s. 133-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26037162 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160729105432 $b ABA008
- 999 __
- $a ok $b bmc $g 1155386 $s 945244
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 114 $c - $d 133-8 $e 20150522 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
- LZP __
- $a Pubmed-20160722